How to combat tuberculosis in the Year 2000?

被引：8

作者：

Rieder, HL ^{[1
]}

机构：

[1] Int Union TB & Lung Dis, TB Div, Paris, France

来源：

RESPIRATION | 1998年 / 65卷 / 06期

关键词：

D O I：

10.1159/000029309

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：423 / 431

页数：9

共 141 条

[11] The clinical pharmacokinetics of rifabutin [J].

Blaschke, TF ;

Skinner, MH .

CLINICAL INFECTIOUS DISEASES, 1996, 22 :S15-S21

[12]

BLOOM BR, 1989, REV INFECT DIS, V11, pS460

[13]

BOTHAMLEY GH, 1995, EUR RESPIR J, V8, pS676

[14] M-tuberculosis genome to be sequenced [J].

Bradbury, J .

LANCET, 1996, 347 (9005) :890-890

[15]

BRITISH THORACIC ASSOCIATION, 1982, American Review of Respiratory Disease, V126, P460

[16] RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].

BRUDNEY, K ;

DOBKIN, J .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749

[17]

BRUMMER DL, 1971, AM REV RESPIR DIS, V104, P454

[18] A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis [J].

Burman, WJ ;

Dalton, CB ;

Cohn, DL ;

Butler, JRG ;

Reves, RR .

CHEST, 1997, 112 (01) :63-70

[19] THE EARLY BACTERICIDAL ACTIVITY OF RIFABUTIN MEASURED BY SPUTUM VIABLE COUNTS IN HONG-KONG PATIENTS WITH PULMONARY TUBERCULOSIS [J].

CHAN, SL ;

YEW, WW ;

MA, WK ;

GIRLING, DJ ;

ABER, VR ;

FELMINGHAM, D ;

ALLEN, BW ;

MITCHISON, DA .

TUBERCLE AND LUNG DISEASE, 1992, 73 (01) :33-38

[20] 11 YEARS OF COMMUNITY-BASED DIRECTLY OBSERVED THERAPY FOR TUBERCULOSIS [J].

CHAULK, CP ;

MOORERICE, K ;

RIZZO, R ;

CHAISSON, RE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12) :945-951

← 1 2 3 4 5 6 7 8 9 10 →